Skip to main content
Past Event

Expert Workshop: Setting Priorities for Methods Research and Development for Active Medical Product Surveillance

On June 3, the Engelberg Center hosted an expert workshop on setting priorities for methods research and development for active medical product surveillance.

 

This technical workshop focused on topics including lessons learned, current activities, and anticipated needs for methods research and development. Presentations from a wide range of key stakeholders – including representatives from the U.S. Food and Drug Administration, the Observational Medical Outcomes Partnership, and Mini-Sentinel – aimed to develop a practical agenda for advancing this work.

Learn about our other Expert Workshops »

Agenda

Welcome, Overview, and Meeting Objectives

Mark B. McClellan

Former Brookings Expert

Mark McClellan is a senior fellow and director of the Health Care Innovation and Value Initiative at Brookings. He has written a number of publications on care delivery reform, physician payment reform, and accountable care implementation in the U.S. and abroad.

FDA's Perspective on the Current Status and Future of Active Medical Product Surveillance and Safety Science

J

Janet Woodcock

Director, Center for Drug Evaluation and Research - US Food and Drug Administration

Methods Research and Development: Lessons Learned, Current Activities, and Existing Gaps

J

Judy Racoosin

Sentinel Initiative Scientific Lead, Office of Medical Policy, Center for Drug Evaluation and Research

Moderated Discussion

R

Robert Ball

Deputy Director of the Office of Surveillance and Epidemiology - U.S. Food and Drug Administration

Developing an Agenda to Advance Methods Research and Development

R

Richard Platt

Professor and Chair, Department of Population Medicine - Harvard Pilgrim Health Care Institute

P

Paul Stang

Johnson & Johnson and the Observational Medical Outcomes Partnership

Moderated Discussion

R

Robert Ball

Deputy Director of the Office of Surveillance and Epidemiology - U.S. Food and Drug Administration

Closing Remarks

Mark B. McClellan

Former Brookings Expert

Mark McClellan is a senior fellow and director of the Health Care Innovation and Value Initiative at Brookings. He has written a number of publications on care delivery reform, physician payment reform, and accountable care implementation in the U.S. and abroad.

More Information

More

Get a weekly events calendar from Brookings